Interventional Oncology Devices – Market Insights – Asia Pacific
Despite the short term challenges posed by the COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth through 2031 driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of new competitors. However, a lack of reimbursement and pricing pressures will continue to remain a challenge.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the Asia Pacific region from 2019 to 2031.
The COVID-19 pandemic had short-term consequences on the interventional oncology device market, but the market has begun to see a recovery towards pre-pandemic levels.
What procedure types of the interventional oncology market were impacted the most by COVID-19?
What will the recoveries look like for different procedure categories over the forecast period?
Physicians in the Asia Pacific region are looking for various minimally invasive interventional oncology devices to treat liver, kidney, and lung cancers, and many new interventional oncology companies and products are entering the market.
What are the major demographic, economic, and local trend differences across the Asia Pacific region that impact the adoption of and demand for these devices?
What technologies are available, and which products are set to be launched in the different countries going forward?
Reimbursement will be an important factor in the adoption of interventional oncology procedures in the Asia Pacific region.
What is the reimbursement scenario in the different Asia Pacific countries?
How will reimbursement impact the interventional oncology market?
Microwave ablation devices are growing in popularity among interventional oncologists.
What factors are driving the uptake of each of the ablation device types across the Asia Pacific countries?
How does the uptake of microwave ablation devices affect other types of ablation devices, like RF ablation devices, and how are competitors preparing for this shift?
Table of contents
- Interventional Oncology Devices - Market Insights - Asia Pacific
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Interventional Oncology Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Interventional Oncology Device Market Landscape, Asia Pacific (USD), 2021 and 2031
- Competitive Highlights
- Interventional Oncology Device Revenue Market Share Rankings, by Product Type, Asia Pacific, 2021
- Companies Mentioned
- Market Developments
- Recent Events in the Interventional Oncology Device Market, Asia Pacific
- Key Clinical Trials in the Interventional Oncology Device Market, Asia Pacific
- Emerging Products in the Interventional Oncology Device Market, Asia Pacific
- Geographies Covered
- Geographies Covered, Asia Pacific
- Average Currency Exchange Rates
- Procedures Covered
- Interventional Oncology Procedures Covered, Asia Pacific
- Products Covered
- Interventional Oncology Products Covered, Asia Pacific
- COVID-19 Updates
- Key Report Updates
- COVID-19 Analysis
- Market Impact
- COVID-19 Impact Assessment Summary, Interventional Oncology Device Market, Asia Pacific
- Major Market Forecast Changes and Assumptions
- Interventional Oncology Device Market, by Product Type, Asia Pacific (USD), 2019u20132031 (Excluding COVID-19 Impact)
- Interventional Oncology Device Market, by Product Type, Asia Pacific (USD), 2019u20132031 (Including COVID-19 Impact)
- Competitive Impact
- COVID-19 Competitive Factors and Strategies, Interventional Oncology Device Market, Asia Pacific
- COVID-19 Financial Impact and Competitor Insights
- Market Impact
- Interventional Oncology Device Market
- Market Highlights
- Key Content Updates
- Asia Pacific Interventional Oncology Device Market Drivers
- Asia Pacific Interventional Oncology Device Market Limiters
- End-User Insights
- Interventional Oncology Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Interventional Oncology Procedures, by Indication, Asia Pacific, 2019u20132031
- Interventional Oncology Procedures, by Procedure Type, Asia Pacific, 2019u20132031
- Interventional Oncology Procedures, by Country, Asia Pacific, 2019u20132031
- Interventional Oncology Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Interventional Oncology Device Market Growth, by Product Type, Asia Pacific, 2020u20132031
- Interventional Oncology Device Market, by Country, Asia Pacific (USD), 2019u20132031
- Interventional Oncology Device Market Growth, by Country, Asia Pacific, 2020u20132031
- Competitive Insights
- Medtronic Competitive Insights
- Boston Scientific Competitive Insights
- Terumo Competitive Insights
- Merit Medical Systems Competitive Insights
- Competitive Insights for Other Key Competitors
- Factors Affecting All Competitors
- Market Shares
- Interventional Oncology Device Revenue Market Shares, Asia Pacific, 2021
- Interventional Oncology Device Revenue Market Shares, by Product Type, Asia Pacific, 2021
- Market Developments
- Recent Events in the Interventional Oncology Device Market, Asia Pacific
- Key Clinical Trials in the Interventional Oncology Device Market, Asia Pacific
- Emerging Products in the Interventional Oncology Device Market, Asia Pacific
- Market Highlights
- Ablation Device Market
- Market Highlights
- Key Content Updates
- Asia Pacific Ablation Device Market Drivers
- Asia Pacific Ablation Device Market Limiters
- End-User Insights
- Ablation Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Ablation Procedures, by Indication, Asia Pacific, 2019u20132031
- Ablation Procedures, by Product Type, Asia Pacific, 2019u20132031
- Ablation Procedures, by Country, Asia Pacific, 2019u20132031
- Primary Liver Cancer Ablation Procedures, by Product Type, Asia Pacific, 2019u20132031
- Primary Liver Cancer Ablation Procedures, by Country, Asia Pacific, 2019u20132031
- Secondary Liver Cancer Ablation Procedures, by Product Type, Asia Pacific, 2019u20132031
- Secondary Liver Cancer Ablation Procedures, by Country, Asia Pacific, 2019u20132031
- Kidney Cancer Ablation Procedures, by Product Type, Asia Pacific, 2019u20132031
- Kidney Cancer Ablation Procedures, by Country, Asia Pacific, 2019u20132031
- Lung Cancer Ablation Procedures, by Product Type, Asia Pacific, 2019u20132031
- Lung Cancer Ablation Procedures, by Country, Asia Pacific, 2019u20132031
- Ablation Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Ablation Device Market Growth, by Product Type, Asia Pacific, 2020u20132031
- Ablation Device Market, by Country, Asia Pacific (USD), 2019u20132031
- Ablation Device Market Growth, by Country, Asia Pacific, 2020u20132031
- Microwave Ablation Procedures, by Indication, Asia Pacific, 2019u20132031
- Microwave Ablation Procedures, by Country, Asia Pacific, 2019u20132031
- Microwave Ablation Device Market, by Country, Asia Pacific (USD), 2019u20132031
- Microwave Ablation Device Market Growth, by Country, Asia Pacific 2020u20132031
- RF Ablation Procedures, by Country, Asia Pacific, 2019u20132031
- RF Ablation Procedures, by Indication, Asia Pacific, 2019u20132031
- RF Ablation Device Market, by Country, Asia Pacific (USD), 2019u20132031
- RF Ablation Device Market Growth, by Country, Asia Pacific, 2020u20132031
- Cryoablation Procedures, by Indication, Asia Pacific, 2019u20132031
- Cryoablation Procedures, by Country, Asia Pacific, 2019u20132031
- Cryoablation Device Market, by Country, Asia Pacific (USD), 2019u20132031
- Cryoablation Device Market Growth, by Country, Asia Pacific, 2020u20132031
- IRE Ablation Procedures, by Country, Asia Pacific, 2019u20132031
- IRE Ablation Device Market, by Indication, Asia Pacific, 2019u20132031
- IRE Ablation Device Market, by Country, Asia Pacific (USD), 2019u20132031
- IRE Ablation Device Market Growth, by Country, Asia Pacific (USD), 2020u20132031
- Market Shares
- Ablation Device Revenue Market Shares, Asia Pacific, 2021
- Ablation Device Revenue Market Shares, by Product Type, Asia Pacific, 2021
- Competitive Insights
- Market Highlights
- Embolization Device Market
- Market Highlights
- Key Content Updates
- Asia Pacific Embolization Device Market Drivers
- Asia Pacific Embolization Device Market Limiters
- End-User Insights
- Embolization Particle Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Embolization Particle Procedures, by Indication, Asia Pacific, 2019u20132031
- Embolization Particle Procedures, by Country, Asia Pacific, 2019u20132031
- Embolization Particle Procedures, by Product Type, Asia Pacific, 2019u20132031
- Primary Liver Cancer Embolization Particle Procedures, by Product Type, Asia Pacific, 2019u20132031
- Secondary Liver Cancer Embolization Particle Procedures, by Product Type, Asia Pacific, 2019u20132031
- Kidney Cancer Embolization Particle Procedures, by Product Type, Asia Pacific, 2019u20132031
- Embolization Particle Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Embolization Particle Market Growth, by Product Type, Asia Pacific, 2020u20132031
- Embolization Particle Market, by Country, Asia Pacific (USD), 2019u20132031
- Embolization Particle Market Growth, by Country, Asia Pacific, 2020u20132031
- Radioembolization Procedures, by Indication, Asia Pacific, 2019u20132031
- Radioembolization Procedures, by Country, Asia Pacific, 2019u20132031
- Radioembolization Sphere Market, by Country, Asia Pacific (USD), 2019u20132031
- Radioembolization Sphere Market Growth, by Country, Asia Pacific, 2020u20132031
- DEB Procedures, by Indication, Asia Pacific, 2019u20132031
- DEB Procedures, by Country, Asia Pacific, 2019u20132031
- DEB Market, by Country, Asia Pacific (USD), 2019u20132031
- DEB Market Growth, by Country, Asia Pacific, 2020u20132031
- Microsphere Procedures, by Indication, Asia Pacific, 2019u20132031
- Microsphere Procedures, by Country, Asia Pacific, 2019u20132031
- Microsphere Market, by Country, Asia Pacific (USD), 2019u20132031
- Microsphere Market Growth, by Country, Asia Pacific, 2020u20132031
- PVA Particle Procedures, by Indication, Asia Pacific, 2019u20132031
- PVA Particle Procedures, by Country, Asia Pacific, 2019u20132031
- PVA Particle Market, by Country, Asia Pacific (USD), 2019u20132031
- PVA Particle Sphere Market Growth, by Country, Asia Pacific, 2020u20132031
- Market Shares
- Embolization Device Revenue Market Shares, Asia Pacific, 2021
- Embolization Device Revenue Market Shares, Asia Pacific, 2021
- Competitive Insights
- Market Highlights
- Accessory Device Market
- Market Highlights
- Key Content Updates
- Asia Pacific Accessory Device Market Drivers
- Asia Pacific Accessory Device Market Limiters
- Accessory Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Accessory Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Accessory Device Market Growth, by Product Type, Asia Pacific, 2020u20132031
- Accessory Device Market, by Country, Asia Pacific (USD), 2019u20132031
- Accessory Device Market Growth, by Country, Asia Pacific, 2020u20132031
- Guide Catheter Market, by Country, Asia Pacific (USD), 2019u20132031
- Guide Catheter Market Growth, by Country, Asia Pacific (USD), 2020u20132031
- Microcatheter Market, by Country, Asia Pacific (USD), 2019u20132031
- Microcatheter Market Growth, by Country, Asia Pacific (USD), 2020u20132031
- Angiography Catheter Market, by Country, Asia Pacific (USD), 2019u20132031
- Angiography Catheter Market Growth, by Country, Asia Pacific (USD), 2020u20132031
- Guidewire Market, by Country, Asia Pacific (USD), 2019u20132031
- Guidewire Market Growth, by Country, Asia Pacific (USD), 2020u20132031
- Sheath Market, by Country, Asia Pacific (USD), 2019u20132031
- Sheath Market Growth, by Country, Asia Pacific (USD), 2020u20132031
- Market Shares
- Accessory Device Revenue Market Shares, Asia Pacific, 2021
- Accessory Devices Revenue Market Shares, by Product Type, Asia Pacific, 2021
- Competitive Insights
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Pankhil Gandhi is an analyst within the Cardiovascular Medtech Insights team at Clarivate, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.